UNSPSC 51273824: Eucalyptus/menthol/methyl salicylate/triethanolamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE650. This VA Drug Class (DE650) classifies this compound as belonging to the group ANALGESICS, TOPICAL.

UNSPSC 51273824 Eucalyptus/menthol/methyl salicylate/triethanolamine is a Commodity code that shows little relevant recent activity aligned with its nominal scope. The three most recent opportunities posted under this code—Seminole County's procurement of naloxone and drug deactivation systems, Texas HHS's Request for Information on direct-to-manufacturer prescriptions, and Minnesota's MMCAP cooperative purchasing RFP for generic pharmaceuticals and OTC products—do not reflect purchases of the topical analgesic and anti-inflammatory compounds the code nominally describes. The mismatch suggests either systematic miscoding in state and local procurement systems or that the code has been repurposed in practice to capture broader pharmaceutical and medical-supply procurement that does not fit the specific chemical formulations named in the UNSPSC taxonomy. State and local buyers appear to use this code as a catch-all for health department and human services pharmaceutical acquisitions rather than as a targeted reference for the specialty chemical ingredients the code title implies.

The issuing bodies include a county health department (Seminole County, Florida), a state health and human services agency (Texas HHS), and a multistate cooperative purchasing vehicle (Minnesota MMCAP, with Oregon participation). Geographic activity spans Florida, Texas, and the Upper Midwest, though the sample is too small and misaligned with the code's nominal scope to support reliable pattern inference. The Seminole County IFB closed July 26, 2023, seeking 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries; the Texas HHS RFI closed April 3, 2026, gathering vendor capabilities for direct-to-manufacturer prescription programs; and the Minnesota MMCAP RFP closed March 26, 2026, seeking generic multi-source pharmaceuticals and OTC products for distribution across state and local facilities. No opportunities under this code align with the eucalyptus, menthol, methyl salicylate, or triethanolamine products the UNSPSC number names, making pursuit under the code's stated chemical scope not viable based on current market activity.